Wall R, Strong L
Nature. 1987;327(6121):418-21. doi: 10.1038/327418a0.
Ivermectin (22,23-dihydroavermectin B1) is a recently discovered, persistent, broad-spectrum, antiparasitic drug of unpredecented potency which is now routinely administered to cattle, horses, sheep and pigs in many countries. In cattle, it is an efficient control for parasitic gastrointestinal and respiratory tract nematodes, warble fly, mites, lice and ticks. However, most of the ivermectin dose is ultimately eliminated in the faeces of the treated animals where it has been shown to have an insecticidal effect on the larvae of economically important, dung-breeding, haematophagous Diptera. Nevertheless, the effects of excreted ivermectin on the cowpat fauna as a whole and the wider consequences of such effects have not previously been considered. In field trials reported here, the faeces of calves fitted with rumenal boluses delivering ivermectin at 40 micrograms per kg per day, failed to degrade in the normal way and this failure was associated with the absence of dung-degrading insects. Faeces from placebo-treated controls contained a characteristic dung-degrading invertebrate community and were largely degraded within 100 days. These results indicate that the increasing widespread use of ivermectin may have important environmental consequences for pastureland.
伊维菌素(22,23 - 二氢阿维菌素B1)是一种最近发现的、长效、广谱、具有空前效力的抗寄生虫药物,目前在许多国家已常规用于牛、马、羊和猪。对牛而言,它能有效防治寄生性胃肠道和呼吸道线虫、皮蝇、螨、虱和蜱。然而,大部分伊维菌素剂量最终会在接受治疗动物的粪便中排出,已证明其对具有经济重要性的、在粪便中繁殖的吸血双翅目幼虫具有杀虫作用。尽管如此,此前尚未考虑过排出的伊维菌素对牛粪动物群整体的影响以及此类影响的更广泛后果。在此报告的田间试验中,装有瘤胃丸剂、每天每千克体重释放40微克伊维菌素的小牛粪便未能以正常方式降解,这种降解失败与缺乏粪便降解昆虫有关。接受安慰剂治疗的对照组的粪便含有典型的粪便降解无脊椎动物群落,并且在100天内基本降解。这些结果表明,伊维菌素日益广泛的使用可能会对牧场产生重要的环境影响。